Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulin
US6444642B1 · kind B1 · utility
36Cited by
4References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Sep 3, 2002 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of treating diseases and disorders of the muscle tissues in a vertebrate by the administration of compounds which bind the p185erbB2 receptor. These compounds are found to cause increased differentiation and survival of cardiac, skeletal and smooth muscle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.